Patent Assignment
Reel/Frame 048062/0807
Security Interest
Recorded: 2019-01-18
Pages: 9
Assignor
NABRIVA THERAPEUTICS GMBH
Executed: 2019-01-08
Assignee
HERCULES CAPITAL, INC.
400 HAMILTON AVENUE, SUITE 310, PALO ALTO, CALIFORNIA, 94301
Covered Properties
(7)
Pleuromutilin Derivatives Having Antibacterial Activity
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Enantiomerically Pure Amines
Process for the Preparation of Pleuromutilins
Injectable Pharmaceutical Formulations of Lefamulin
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
16/023,880 →
Publication:
US 2018/0303842
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 10, 2004
From: ASCHER, GERD; BERNER, HEINZ
To: SANDOZ GMBH (FORMERLY BIOCHEMIE GMBH)
Reel/Frame 015311/0040 →
Assignment of Assignor's Interest
Aug 13, 2008
From: SANDOZ GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 021380/0209 →
Assignment of Assignor's Interest
Sep 17, 2009
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 023249/0229 →
Assignment of Assignor's Interest
Feb 22, 2012
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 027745/0615 →
Assignment of Assignor's Interest
Nov 27, 2012
From: RIEDL, ROSEMARIE; HEILMAYER, WERNER; SPENCE, LEE; BULUSU, ATCHYUTA RAMA CHANDRA MURTY
To: NABRIVA THERAPEUTICS AG
Reel/Frame 029355/0554 →
Assignment of Assignor's Interest
Dec 10, 2012
From: RIEDL, ROSEMARIE; HEILMAYER, WERNER; SPENCE, LEE
To: NABRIVA THERAPEUTICS AG
Reel/Frame 029439/0875 →
Security Interest
Aug 28, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033647/0657 →
Lien
Sep 3, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033659/0216 →
Assignment of Assignor's Interest
Oct 13, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033935/0048 →
Release of Security Interest
Nov 19, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037093/0308 →
Corrective Assignment to Correct the Application No. in the Release by Secured Party from 12/699585 to 13/699585 Previously Recorded on Reel 037093 Frame 0308. Assignor(S) Hereby Confirms the Release Agreement.
Dec 2, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037190/0424 →
Release of Security Interest
Jan 11, 2016
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037455/0436 →
Release of Security Interest
Sep 29, 2016
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 039894/0473 →
Assignment of Assignor's Interest
Mar 7, 2018
From: FERENCIC, MATHIAS; HEILMAYER, WERNER; HINSMANN, PETER; WICHA, WOLFGANG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 045131/0353 →
Change of Name
May 17, 2018
From: NABRIVA THERAPEUTICS AG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 047658/0862 →
Change of Name
Jul 18, 2018
From: NABRIVA THERAPEUTICS AG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 047958/0106 →
Entity Conversion
Sep 28, 2018
From: NABRIVA THERAPEUTICS AG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 047160/0234 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Release of Security Interest
Jul 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064326/0977 →
Assignment of Assignor's Interest
Jan 9, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 069806/0458 →
Nunc Pro Tunc Assignment
Apr 3, 2025
From: NABRIVA THERAPEUTICS GMBH
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 070725/0291 →